- Research works
- 22 ▲ 108% vs 2018-21
- Citations
- 321 14.3 per fractional work
- Top-10% rate
- 4.3% all institutions 10.0%
- Open access
- 34% world 40%
- International
- 10% world 18%
Not ranked overall: Cel-Sci (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Cel-Sci (United States) work in?
In all years, 39% of research at Cel-Sci (United States) is in Life Sciences, 32% in Health Sciences. Its largest fields are Immunology and Microbiology (31%), Medicine (30%), Engineering (15%). It does 1.9× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Life Sciences939.4%
- Health Sciences732.0%
- Medicine729.7%
- Health Professions01.2%
- Dentistry01.1%
- Physical Sciences419.9%
- Engineering315.5%
- Chemistry14.4%
- Social Sciences28.6%
- Business, Management and Accounting15.1%
- Social Sciences01.7%
- Psychology01.5%
- Decision Sciences00.3%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Cel-Sci (United States)?
Ranked on the quality score, Eyal Talor and Daniel H. Zimmerman lead among researchers whose main affiliation is Cel-Sci (United States).
- 1
Eyal Talor
United States · #3,836,341 worldwide 359 citations · 32 works
- 2
Daniel H. Zimmerman
United States · #6,220,581 worldwide 938 citations · 78 works
Which keywords describe research at Cel-Sci (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Antigen Presentation, Immunity, Innate Immunity, Cancer Immunotherapy, Dendritic Cells, Vaccine, Glycosylation and Immune Response.
- Synthesis
- Online Dispute Resolution
- Traffic Flow
- NK Cell Recognition
- Peptide-MHC Binding
- Therapeutic Antibodies
- Foxp3
- Autoimmunity
- Glycosylation
- Vaccine
- Cancer Immunotherapy
- Immunity
- Antigen Presentation
- Innate Immunity
- Dendritic Cells
- Epidemiology
- Immune Response
- Fc Receptors
- TGF-ß
- Epitope Prediction
- Intelligent Transportation Systems
- Natural Killer Cells
- Global Trade
- Quinoxaline
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Antigen Presentation4▲ 179×2 topics
- Immunity3▲ 39×2 topics
- Innate Immunity3▲ 37×2 topics
- Cancer Immunotherapy3▲ 88×1 topic
- Dendritic Cells3▲ 106×1 topic
- Vaccine2▲ 24×6 topics
- Epidemiology2▲ 2.1×9 topics
- Glycosylation2▲ 38×3 topics
- Immune Response2▲ 13×6 topics
- Autoimmunity2▲ 37×2 topics
- Fc Receptors2▲ 73×1 topic
- Foxp32▲ 96×1 topic
- TGF-ß2▲ 42×1 topic
- Therapeutic Antibodies2▲ 57×1 topic
- Epitope Prediction1▲ 301×1 topic
- Peptide-MHC Binding1▲ 301×1 topic
- Intelligent Transportation Systems1▲ 58×2 topics
- NK Cell Recognition1▲ 51×1 topic
- Natural Killer Cells1▲ 51×1 topic
- Traffic Flow1▲ 84×2 topics
- Global Trade1▲ 33×1 topic
- Online Dispute Resolution1▲ 471×1 topic
- Quinoxaline1▲ 98×1 topic
- Synthesis1▲ 7.6×1 topic
Which research topics does Cel-Sci (United States) publish most on?
By volume in 2022-now: Head and Neck Cancer Studies, Peptidase Inhibition and Analysis, Radiomics and Machine Learning in Medical Imaging and Medical Imaging Techniques and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Head and Neck Cancer Studies Otorhinolaryngology 1 works
- 2 Peptidase Inhibition and Analysis Oncology 0 works
- 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
- 4 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 5 Immunotherapy and Immune Responses Immunology 0 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 8 Oral Health Pathology and Treatment Periodontics 0 works
- 9 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 10 vaccines and immunoinformatics approaches Molecular Biology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Cel-Sci (United States)'s research output changed?
Output in 2022-2025 was 108% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Cel-Sci (United States) as a percentage of every work published that year, 0.0000036% in 2024.
Fractional works of Cel-Sci (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Vienna
- Defense Systems (United States)
- The Jane Goodall Institute
- Association of Organ Procurement Organizations
- National Court Reporters Association
- Brain Injury Association of America
- Primus Consulting (United States)
- International Association for K-12 Online Learning
- Shared Spectrum Company (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Cel-Sci (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.